David Or Goliath: Where Is Innovation Winning Through?
An Interview With KSQ’s David Meeker
Executive Summary
With both a big pharma and biotech leadership perspective, David Meeker talks to In Vivo about how smaller firms can more easily fly solo in drug development, challenges effecting the innovative drug development sector in 2019 and the partnering environment for cell and gene therapy companies.